Antiangiogenesis Treatment for Glioblastoma Multiforme: Challenges and Opportunities

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.5, 2008-05, pp. : 515-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Temozolomide in the Treatment of Recurrent Glioblastoma Multiforme

By Martikainen Janne A.

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 803-815

Adis International

Access to resources Recommend Favorite

Novel chemotherapeutic agents for the treatment of glioblastoma multiforme

By Jendrossek Verena Belka Claus Bamberg Michael

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 1899-1924

Informa Healthcare

Access to resources Recommend Favorite

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

Current Radiopharmaceuticals, Vol. 5, Iss. 4, 2012-10 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

PKCη as a therapeutic target in glioblastoma multiforme

By Martin Patrick M Hussaini Isa M

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 299-313

Informa Healthcare

Access to resources Recommend Favorite

Glioblastoma multiforme: a review of therapeutic targets

By Kanu Okezie O Mehta Ankit Di Chunhui Lin Ningjing Bortoff Kathy Bigner Darell D Yan Hai Adamson David Cory

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 701-718

Informa Healthcare

Access to resources Recommend Favorite